Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 49 (RPL31P49) is a non-coding pseudogene present in the human genome, with sequence similarity to the ribosomal protein L31 gene (RPL31)[2][6][12]. Unlike the functional ribosomal protein L31, which is a structural component of the large 60S ribosomal subunit involved in protein synthesis, RPL31P49 does not produce a functional protein and does not have known biological or therapeutic roles. Such processed pseudogenes are common for ribosomal protein genes and generally do not perform cellular functions[3][5][9][12]. RPL31P49 is a non-functional, non-coding pseudogene, not a therapeutic target, and does not have molecular, biological, or clinical roles beyond its identification as a genomic locus with sequence similarity to a protein-coding ribosomal protein gene[2][6][12].
None (not targeted by drugs; no known mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 49 (RPL31P49).